No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone.
Br J Clin Pharmacol. 2008 Jan;65(1):78-86. doi: 10.1111/j.1365-2125.2007.02986.x. Epub 2007 Jul 17.
Br J Clin Pharmacol. 2008.
PMID: 17635496
Free PMC article.
Clinical Trial.